We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

CANNABIDIOL CONSUMER HEALTH MARKET ANALYSIS

Cannabidiol (CBD) Consumer Health Market, By Products, By Distribution Channel, By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

  • Published In : Aug 2023
  • Code : CMI6126
  • Pages :180
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Regional Analysis

Global Cannabidiol (CBD) Consumer Health Market: Regional Insights

  • Based on geography, the global cannabidiol (CBD) consumer health market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • Among regions, North America is expected to gain highest share in the market during the forecast period due to recent global policy changes that have increased access to medical cannabis or cannabinoid-based pharmacotherapeutics in this region. For instance, in July 2020, according to the article published in National Center for Biotechnology Information, In U.S. for example, medical cannabis use is legal in 33 states and the District of Columbia (D.C.) and non-medical use is legal in 11 states. In addition to cannabis, the legalization of hemp has expanded in many countries. Indeed, with the approval of the U.S. Agriculture Improvement Act of 2018, hemp and its derivative products are no longer considered controlled substances by the U.S Drug Enforcement Administration. These legislative changes have led to the emergence of a large, and growing, retail market of cannabinoid-based products.
  • Europe region is also expected to witness significant growth in the global cannabidiol (CBD) consumer health market due to the rise in burden of cancer, owing to the increasing awareness for products developed to improve neurological health in these region. For instance, a real-data study programme was initiated in February 2023 as part of a 12-month collaboration between the UK Scientific Body and the patient advocacy group Medcan Support to examine the potential benefits of medical cannabis for treating childhood epilepsy symptoms. The goal of this programme is to create a new viewpoint on cannabis use in the medical field.
Geographies covered:
  • North America: U.S. and Canada
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Middle East and Africa: GCC Countries, Israel, Rest of Middle East, South Africa, North Africa, and Central Africa.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.